Mycoplasma hominis pneumonia complicating bilateral lung transplantation: Case report and review of the literature

Chest

Volumn 112, Issue 5, 1997, Pages 1428-1432

  Lyon, G Marshall ^a   Alspaugh, J Andrew ^a   Meredith, Fran T ^a   Harrell, Lizzie J ^a   Tapson, Victor ^a   Davis, R Duane ^a   Kanj, Souha S ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; OFLOXACIN; TETRACYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; HUMAN; LUNG EMBOLISM; LUNG TRANSPLANTATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA HOMINIS; MYCOPLASMA PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; UREAPLASMA UREALYTICUM;

EID: 0030670121     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.5.1428     Document Type: Article

References (30)

1. Madoff S, Hooper DC. Nongenitourinary infections caused by Mycoplasma hominis in adults. Rev Infect Dis 1988; 10:602-13
2. McMahon DK, Dummer JS, Pasculle AW, et al. Extragenital Mycoplasma hominis infections in adults. Am J Med 1990; 89:275-81
3. Meyer RD, Clough W. Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression. Clin Infect Dis 1993; 17(suppl 1):S243-49
4. Luttrell LM, Kanj SS, Corey GR, et al. Mycoplasma hominis septic arthritis: two case reports and review. Clin Infect Dis 1994; 19:1067-70
5. Mufson MA. Mycoplasma hominis: a review of its role as a respiratory tract pathogen of humans. Sex Transm Dis 1983; 10(suppl 4):S335-40
6. Taylor-Robinson D. Ureaplasma urealyticum and Mycoplasma hominis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995; 1713-17
7. Berman SM, Harrison HR, Boyce WT, et al. Low birth weight, prematurity, and postpartum endometritis: association with prenatal cervical Mycoplasma hominis and Chlamydia trachomatis infections. JAMA 1987; 257:1189-94
8. Waites Bw, Bebear C, Robertson JA, et al. Laboratory diagnosis of mycoplasmal and ureaplasmal infections. Clin Microbiol Newslett 1996; 18: 105-12
9. Parides GC, Bloom JW, Ampel NM, et al. Mycoplasma and Ureaplasma in bronchoalveolar lavage fluids from immunocompromised hosts. Diagn Microbiol Infect Dis 1988; 9: 55-57
10. Bygdeman SM, Mardh PA. Antimicrobial susceptibility and susceptibility testing of Mycoplasma hominis: a review. Sex Transm Dis 1983; 10(suppl):S366-70
11. Braun P, Klein JO, Kass EH. Susceptibility of genital mycoplasmas to antimicrobial agents. Appl Microbiol 1970; 19: 62-70
12. Bébéar C, Robertson JA. Determination of minimal inhibitory concentration. In: Tully JG, Razin S, eds. Molecular and diagnostic procedures in mycoplasmology, volume II. San Diego: Academic Press, 1996; 189-97
13. Tully JG, Smith LG. Postpartum septicemia with Mycoplasma hominis. JAMA 1968; 204:827-28
14. Kenny RT, Li JS, Clyde WA Jr, et al. Mycoplasma pericarditis: evidence of invasive disease. Clin Infect Dis 1993; 7(suppl 1):S58-S62
15. Orange GV, Jones M, Henderson IS. Wound and perinephric haematoma infection with Mycoplasma hominis in a renal transplant recipient. Nephrol Dial Transplant 1993; 8:1395-96
16. Steffenson DO, Dummer JS, Granick MS, et al. Sternotomy infections with Mycoplasma hominis. Ann Intern Med 1987; 106:204-08
17. Ridgwav EJ, Allen KD. Mycoplasma hominis abscess secondary to respiratory tract infection. J Infect 1994; 29:207-10
18. Kane JR, Shenep JL, Krance RA, et al. Diffuse alveolar hemorrhage associated with Mycoplasma hominis respiratory tract infection in a bone marrow transplant recipient. Chest 1994; 105:1891-92
19. Boyle EM Jr, Burdine J, Bolman RM III. Successful treatment of Mycoplasma mediastinitis after heart-lung transplantation. J Heart Lung Transplant 19935; 12:508-12
20. Jacobs F, Van de Stadt J, Gelin M, et al. Mycoplasma hominis infection of perihepatic hematomas in a liver transplant recipient. Surgery 1992; 111:98-100
21. Spencer RC, Brown CB. Septicaemia in a renal transplant patient due to Mycoplasma hominis. J Infect 1983; 6:267-68
22. Budin RE, Charache P. Use of acridine orange for the presumptive identification of mycoplasma in tissue sections: Mycoplasma hominis interstitial pneumonitis complicating end stage nodular sclerosing Hodgkin's disease (abstract G-2). In: Abstracts of the Annual Meeting of the American Society for Microbiology. Washington, DC: American Society for Microbiology, 1986; 114
23. Baseman JB, Dallo SF, Tully JG, et al. Isolation and characterization of Mycoplasma hominis strains from the human respiratory tract. J Clin Microbiol 1988; 26:2266-69
24. Mufson MA, Chang V, Gill V, et al. The role of viruses, Mycoplasmas, and bacteria in acute pneumonia in civilian adults. Am J Epidemiol 1967; 86:526-44
25. TET M sequences. Antimicrob Agents Chemother 1985; 28:141-43
26. Koutsky LA, Stamm WE, Brunham RC, et al. Persistence of Mycoplasma hominis after therapy: importance of tetracycline resistance and of coexistence vaginal flora. Sex Transm Dis 1983; 10:374-81
27. Kenny GE, Hooton TM, Roberts MC, et al. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agents Chemother 1989; 33:103-07
28. Kenny GE, Cartwright PD. Susceptibilities of mycoplasma pneumonia. Mycoplasma hominis and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99, 219). Antimicrob Agents Chemother 1996; 40:1048-49
29. Lefevre JC, Bauriaud R, Gaubert E, et al. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens. Chemotherapy 1992; 38:303-07
30. Segreti J. In vitro activity of temafloxacin against pathogens causing sexually transmitted diseases. Am J Med 1991; 91: 24s-26s